Medical and Recreational Marijuana Company Kaya Holdings, Inc.
(OTCQB:KAYS)
Responds to President Trump's Call for War on Opioid Epidemic with
Cannabis-for-Opioids Swap Program
Program is intended to offer cannabis products in exchange for
opioids in cooperation with law enforcement authorities and
compliance requirements.
Lebanon, Oregon -- November 27, 2017 -- InvestorsHub NewsWire --
Kaya Holdings, Inc. (OTCQB:KAYS),
announced today that it will be holding talks with Oregon state and
local law enforcement authorities and compliance officials to
launch "Kaya Cares", a Cannabis-for-Opioids swap program whereby
people dependent on opioids and wishing to explore cannabis as a
safe alternative can exchange their prescription opioids for
cannabis products at no cost.
"We decided to step up and do our part after President Trump
announced the war on the opioid epidemic," commented Kaya Holdings
CEO Craig Frank, "numerous studies, including those reported by
Newsweek, NBC News, US News and World Report, CNN and others, have
shown that States with legal marijuana programs have declining
rates of opioid addiction, with some states reporting a decrease in
deaths as high as 25%. We want to help people in the communities we
serve, as well as demonstrate that cannabis companies can be part
of the President's solution to the crisis".
KAYS presently operates three Kaya Shack marijuana retail stores
to service the legal medical and recreational marijuana market in
Oregon, with a fourth retail outlet scheduled to open shortly.
Additionally, KAYS recently acquired a 26 acre parcel in Lebanon,
Oregon, on which it plans to develop the Kaya Farms medical and
recreational marijuana grow and manufacturing complex, at which it
plans to explore development of opioid-free cannabis infused pain
relief alternatives.
Adds KAYS Senior Advisor, W. David Jones, " The opioid epidemic
kills an average of 91 Americans a day. Beyond the human cost in
lives and devastated families, the epidemic disrupts our economy
with reduced productivity and increased healthcare costs. We
realize this administration has been reviewing its stance on legal
marijuana and we appreciate US Attorney Jeff Sessions'
clarification to Congress regarding the Cole Amendment. We wish to
heed President Trump's call to create constructive, private sector
based initiatives with high probabilities of success. We believe a
program like Kaya Cares and other initiatives to be undertaken by
KAYS will help transition people away from dangerous opioids,
making the government's war on opioids a little more
successful".
Save the Date- KAYS Conference Call December 20, 2017 2:00 PM
EST
KAYS Shareholders and other interested parties are reminded to
sign up for the Kaya Holdings Annual Shareholder Call on Wednesday,
December 20, 2017 at 2:00 P.M. EST. The call is expected to last
between 60-90 minutes. Among the topics to be discussed in the call
are Kaya Shack store performance, new store development, OLCC
licensing update, new brands to be introduced in 2018, an industry
overview and the acquisition of farmland and the development of
Kaya Farms 100K Square Foot Grow and Manufacturing Facilities.
About Kaya Holdings, Inc. (www.kayaholdings.com)
KAYS (OTCQB:KAYS),
through subsidiaries, produces, distributes and sells legal premium
medical and recreational cannabis products, including flower,
concentrates and oils, and cannabis-infused foods.
In 2014, KAYS, became the first publicly traded company to own
and operate a Medical Marijuana Dispensary. KAYS presently operates
three Kaya Shack OLCC licensed marijuana retail stores to service
the legal medical and recreational marijuana market in Oregon, with
store number four currently under construction and expected to open
in Q-4 of 2017. Additionally, KAYS recently acquired a 26 acre
parcel which it has targeted for development of the Kaya Farms
Medical and Recreational Marijuana Grow and Manufacturing
Complex.
IMPORTANT DISCLOSURE: KAYS is planning execution of its stated
business objectives in accordance with current understanding of
State and Local Laws and Federal Enforcement Policies and
Priorities as it relates to Marijuana (as outlined in the Justice
Department's Cole Memo dated August 29, 2013), and plan to proceed
cautiously with respect to legal and compliance issues. Potential
investors and shareholders are cautioned that AFAI and MJAI will
obtain advice of counsel prior to actualizing any portion of their
business plan (including but not limited to license applications
for the cultivation, distribution or sale of marijuana products,
engaging in said activities or acquiring existing Cannabis
production/sales operations). Advice of counsel with regard to
specific activities of KAYS and MJAI, Federal, State or Local legal
action or changes in Federal Government Policy and/or State and
Local Laws may adversely affect business operations and shareholder
value.
Forward Looking Statements
This press release includes statements that may constitute
"forward-looking" statements, usually containing the words
"believe," "estimate," "project," "expect" or similar expressions.
These statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. Factors that would cause or
contribute to such differences include, but are not limited to,
acceptance of the Company's current and future products and
services in the marketplace, the ability of the Company to develop
effective new products and receive regulatory approvals of such
products, competitive factors, dependence upon third-party vendors,
and other risks detailed in the Company's periodic report filings
with the Securities and Exchange Commission. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this release.
For more information contact Investor Relations:
561-210-7664